Abstract
The mannose receptor (MR) is an important component of the immune system and understanding the structural and conformational characteristics of this receptor is a key aspect of vaccine design. Improved understanding of the role of carbohydrate recognition domains 4-7 (CRDs 4-7) in recognising glycosylated ligands present on the surface of pathogens such as C.albicans, P. carinii, L. donovani, and M. tuberculosis has given new insight into MR vaccine development. Initial studies identified mannan and its derivatives to be important ligands in MR targeting, providing essential knowledge about the MR structural properties. The MR was found to be an early responder in immunogenic pathways. Many attempts have been made to mimic the structural properties of yeast mannan by attaching mannan or mannose to antigenic proteins or peptide epitopes. However, a more detailed understanding of the structural properties of the MR is necessary for the design of targeted vaccines. This review describes the structure of the MR and provides an overview of the use of mannosylated proteins and peptides for vaccine targeting.
Keywords: Dendritic cells, glycosyl, mannan, mannose receptor, peptide vaccine, targeting.
Current Medicinal Chemistry
Title:Targeting the Mannose Receptor with Mannosylated Subunit Vaccines
Volume: 21 Issue: 30
Author(s): B. Sedaghat, R. Stephenson and I. Toth
Affiliation:
Keywords: Dendritic cells, glycosyl, mannan, mannose receptor, peptide vaccine, targeting.
Abstract: The mannose receptor (MR) is an important component of the immune system and understanding the structural and conformational characteristics of this receptor is a key aspect of vaccine design. Improved understanding of the role of carbohydrate recognition domains 4-7 (CRDs 4-7) in recognising glycosylated ligands present on the surface of pathogens such as C.albicans, P. carinii, L. donovani, and M. tuberculosis has given new insight into MR vaccine development. Initial studies identified mannan and its derivatives to be important ligands in MR targeting, providing essential knowledge about the MR structural properties. The MR was found to be an early responder in immunogenic pathways. Many attempts have been made to mimic the structural properties of yeast mannan by attaching mannan or mannose to antigenic proteins or peptide epitopes. However, a more detailed understanding of the structural properties of the MR is necessary for the design of targeted vaccines. This review describes the structure of the MR and provides an overview of the use of mannosylated proteins and peptides for vaccine targeting.
Export Options
About this article
Cite this article as:
Sedaghat B., Stephenson R. and Toth I., Targeting the Mannose Receptor with Mannosylated Subunit Vaccines, Current Medicinal Chemistry 2014; 21 (30) . https://dx.doi.org/10.2174/0929867321666140826115552
DOI https://dx.doi.org/10.2174/0929867321666140826115552 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Benzimidazole: A Milestone in the Field of Medicinal Chemistry
Mini-Reviews in Medicinal Chemistry Isoprenoid Biosynthesis of the Apicoplast as Drug Target
Current Drug Targets Synthesis, In silico Molecular Docking and Pharmacokinetic Studies, In vitro Antimycobacterial and Antimicrobial Studies of New Imidozolones Clubbed with Thiazolidinedione
Current Computer-Aided Drug Design Update on Anti-TNF-Alpha Treatment in Rheumatic Diseases
Current Drug Therapy Fragment-Based Drug Discovery and Molecular Docking in Drug Design
Current Pharmaceutical Biotechnology Emergence in Pyrazolines: Synthetic and Biological Perspective
The Natural Products Journal A Novel Multi-Target Drug Screening Strategy Directed Against Key Proteins of DAPk Family
Combinatorial Chemistry & High Throughput Screening Proteomic Approaches to Studying Drug Targets and Resistance in Plasmodium
Current Drug Targets - Infectious Disorders Advances in Therapy for Psoriasis: An Overview of Infliximab, Etanercept, Efalizumab, Alefacept, Adalimumab, Tazarotene, and Pimecrolimus
Current Pharmaceutical Design A Therapeutic Connection between Dietary Phytochemicals and ATP Synthase
Current Medicinal Chemistry Design, Synthesis and Biological Evaluation of Novel Heterocyclic Fluoroquinolone Citrate Conjugates as Potential Inhibitors of Topoisomerase IV: A Computational Molecular Modeling Study
Current Drug Discovery Technologies Long-Term Treatment With Raltegravir is Associated with Lower Triglycerides and Platelets Count in the Older HIV+ Population: Results from the Ral-Age Study
Current HIV Research Innate Immunity and Primary Biliary Cirrhosis
Current Molecular Medicine Plombage: A Forgotten Surgical Treatment for Pulmonary Tuberculosis
Current Respiratory Medicine Reviews Progress of Biological Agents on Psoriatic Arthritis
Current Pharmaceutical Biotechnology Development of 'S', 'N' Heterocycles as Antimycobacterials Targeting Fatty Acid Biosynthesis
Current Computer-Aided Drug Design Recent Advances in Tuberculosis Vaccine Development
Current Respiratory Medicine Reviews Drug-Induced Liver Injury: Mechanisms, Types and Biomarkers
Current Medicinal Chemistry The β and γ Classes of Carbonic Anhydrase
Current Pharmaceutical Design Nitric Oxide Production and Signaling in Inflammation
Current Drug Targets - Inflammation & Allergy